Pharmacological and Non-pharmacological Treatment for Decompensated Heart Failure: What Is New?
نویسندگان
چکیده
منابع مشابه
Pharmacological and Non-pharmacological Treatment for Decompensated Heart Failure: What Is New?
PURPOSE OF THE REVIEW Acute heart failure (AHF) is a life-threatening clinical condition that requires prompt medical attention. The aim of the current review is to summarise the results of recent clinical trials conducted in patients with AHF. RECENT FINDINGS Several novel compounds have apparently beneficial acute effects on cardiovascular haemodynamics and patients' symptoms, but their adm...
متن کاملPharmacological Treatment of Heart Failure
Optimal treatment of heart failure is important to reduce hospitalization and mortality. In according to recommendation for treatment from major guideline, most patients with HF should be routinely managed with a combination of 3 types of drugs: a diuretic, an ACEI or an ARB, and a beta blocker. The value of these drugs has been established by the results of numerous large-scale clinical trials...
متن کاملAtrial fibrillation and heart failure: natural history and pharmacological treatment.
Atrial fibrillation (AF) is the most common sustained arrhythmia. Congestive heart failure (CHF), an increasingly frequent cardiovascular disorder affecting millions of people world-wide, has become the most important risk factor of AF in developed countries, as a result of ageing populations. Approximately two thirds of patients with CHF are >65 years of age and likely to have AF as a coexiste...
متن کاملNew pharmacological and technological management strategies in heart failure
Heart failure is a complex clinical syndrome resulting from impairment of ventricular filling or ejection of blood associated with symptoms of dyspnea, fatigue, as well as peripheral and/or pulmonary edema. This syndrome is progressive and characterized by worsening quality of life despite escalating levels of care, affecting 5.7 million Americans with an annual cost of over ≥30 billion US doll...
متن کاملTailored acute heart failure treatment The impact of age and comorbidity on new pharmacological treatment models
1.2 Scientific part Background and state of knowledge Revascularization therapy following acute myocardial infarction (AMI) has reduced mortality from approximately 30% in the 1960s to 6-7% at present. However, the mortality observed in AMI patients with cardiogenic shock (CS) exceeds 50% and has hardly improved, despite the introduction of modern treatment strategies. Most CS-related deaths oc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Heart Failure Reports
سال: 2017
ISSN: 1546-9530,1546-9549
DOI: 10.1007/s11897-017-0328-x